QSI icon

Quantum-Si Incorporated

1.20 USD
+0.02
1.69%
Updated Mar 12, 3:59 PM EDT
1 day
1.69%
5 days
-11.76%
1 month
-38.78%
3 months
-33.70%
6 months
33.17%
Year to date
-71.83%
1 year
-35.83%
5 years
-87.69%
10 years
-87.69%
 

About: Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.

Employees: 143

0
Funds holding %
of 7,363 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

215% more capital invested

Capital invested by funds: $45.9M [Q3] → $145M (+$98.8M) [Q4]

161% more call options, than puts

Call options by funds: $5.69M | Put options by funds: $2.18M

86% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 22

74% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 19

11% more funds holding

Funds holding: 106 [Q3] → 118 (+12) [Q4]

1.15% more ownership

Funds ownership: 42.5% [Q3] → 43.65% (+1.15%) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$3.75
212%
upside
Avg. target
$4.63
285%
upside
High target
$5.50
358%
upside

2 analyst ratings

positive
100%
neutral
0%
negative
0%
Alliance Global Partners
Scott Henry
25% 1-year accuracy
1 / 4 met price target
213%upside
$3.75
Buy
Initiated
7 Feb 2025
HC Wainwright & Co.
Swayampakula Ramakanth
22% 1-year accuracy
44 / 198 met price target
358%upside
$5.50
Buy
Reiterated
14 Jan 2025

Financial journalist opinion

Based on 8 articles about QSI published over the past 30 days

Positive
Seeking Alpha
1 day ago
Quantum-Si: A Rose, By Any Other Name, Wouldn't Smell As Sweet
Quantum-Si aims to revolutionize protein sequencing but faces significant technological and competitive challenges. Commercial reception to Quantum-Si's solutions has been lukewarm so far, suggesting a significant improvement in performance will be needed to drive wider adoption. Quantum-Si believes that it can introduce a superior system in the next few years, but this involves significant uncertainty.
Quantum-Si: A Rose, By Any Other Name, Wouldn't Smell As Sweet
Neutral
Seeking Alpha
1 week ago
Quantum-Si incorporated (QSI) Q4 2024 Earnings Call Transcript
Quantum-Si incorporated (NASDAQ:QSI ) Q4 2024 Earnings Conference Call March 3, 2025 4:30 PM ET Company Participants Katherine Atkins - SVP, Commercial Markets Jeff Hawkins - President and CEO Jeff Keyes - CFO Conference Call Participants Kyle Mikson - Canaccord Genuity Douglas Mcpherson - H.C. Wainright Operator Thank you for standing by.
Quantum-Si incorporated (QSI) Q4 2024 Earnings Call Transcript
Neutral
Zacks Investment Research
1 week ago
Quantum-Si Incorporated (QSI) Reports Q4 Loss, Lags Revenue Estimates
Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.18 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.16 per share a year ago.
Quantum-Si Incorporated (QSI) Reports Q4 Loss, Lags Revenue Estimates
Neutral
Business Wire
1 week ago
Quantum-Si Reports Fourth Quarter and Full Year 2024 Financial Results
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports Fourth Quarter and Full Year 2024 Financial Results.
Quantum-Si Reports Fourth Quarter and Full Year 2024 Financial Results
Positive
Zacks Investment Research
2 weeks ago
QuantumSi Set to Report Q4 Earnings: Buy, Sell or Hold the Stock?
QSI's fourth-quarter performance is expected to have benefited from year-end capital spending and new product launches despite competition and stretched valuation.
QuantumSi Set to Report Q4 Earnings: Buy, Sell or Hold the Stock?
Neutral
Business Wire
3 weeks ago
Quantum-Si's Customers and Researchers to Showcase Next-Generation Protein Sequencing™ at AGBT 2025
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si's Customers and Researchers to Showcase Next-Generation Protein Sequencing™ at AGBT 2025.
Quantum-Si's Customers and Researchers to Showcase Next-Generation Protein Sequencing™ at AGBT 2025
Neutral
Business Wire
3 weeks ago
Quantum-Si and Researchers to Showcase Next-Generation Protein Sequencing™ at US HUPO 2025
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si and Researchers to Showcase Next-Generation Protein Sequencing™ at US HUPO 2025.
Quantum-Si and Researchers to Showcase Next-Generation Protein Sequencing™ at US HUPO 2025
Neutral
Business Wire
4 weeks ago
Quantum-Si to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025.
Quantum-Si to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
Neutral
Business Wire
1 month ago
Quantum-Si Establishes Scientific Advisory Board to Shape Next-Generation Proteomic Technologies
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Establishes Scientific Advisory Board to Shape Next-Generation Proteomic Technologies.
Quantum-Si Establishes Scientific Advisory Board to Shape Next-Generation Proteomic Technologies
Neutral
Business Wire
1 month ago
Quantum-Si and IDEX Health & Science to Partner on Optics Module for Proteus™ Instrument
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si and IDEX Health & Science to Partner on Optics Module for Proteus™ Instrument.
Quantum-Si and IDEX Health & Science to Partner on Optics Module for Proteus™ Instrument
Charts implemented using Lightweight Charts™